These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1338048)

  • 1. Modulation of high affinity phenylalkylamine binding sites on cultured human embryonal vascular smooth muscle cells.
    Drímal J
    Gen Physiol Biophys; 1992 Dec; 11(6):555-65. PubMed ID: 1338048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanine nucleotide-binding proteins modulate desmethoxyverapamil binding to calcium channels in vascular smooth muscle.
    Rakotoarisoa L; Mironneau C; Sayet I; Mironneau J
    J Pharmacol Exp Ther; 1991 Oct; 259(1):164-8. PubMed ID: 1656017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
    Hagiwara M; Adachi-Akahane S; Nagao T
    J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective modulation by membrane potential of desmethoxyverapamil binding to calcium channels in rat portal vein.
    Rakotoarisoa L; Sayet I; Mironneau C; Mironneau J
    J Pharmacol Exp Ther; 1990 Dec; 255(3):942-7. PubMed ID: 2175807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
    Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
    J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
    Reynolds IJ; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel high affinity class of Ca2+ channel blockers.
    Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
    Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
    Liu J; Bangalore R; Rutledge A; Triggle DJ
    Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-operated calcium-permeable channels in vascular smooth muscle.
    Rüegg UT; Wallnöfer A; Weir S; Cauvin C
    J Cardiovasc Pharmacol; 1989; 14 Suppl 6():S49-58. PubMed ID: 2478825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of multiple [3H]ryanodine binding sites on the Ca2+ release channel of sarcoplasmic reticulum from skeletal and cardiac muscle: evidence for a sequential mechanism in ryanodine action.
    Pessah IN; Zimanyi I
    Mol Pharmacol; 1991 May; 39(5):679-89. PubMed ID: 1851961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of binding of 3H-desmethoxyverapamil and 3H-mibefradil in vascular smooth muscle and heart membranes. Possible binding of mibefradil to a site distinct from the phenylalkylamine-binding site.
    Ratner EI; Bochkov VN; Tkachuk VA
    Arzneimittelforschung; 1996 Oct; 46(10):953-5. PubMed ID: 8931886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    Wei XY; Rutledge A; Triggle DJ
    Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SR33557, an indolizinsulfone blocker of Ca2+ channels: identification of receptor sites and analysis of its mode of action.
    Schmid A; Romey G; Barhanin J; Lazdunski M
    Mol Pharmacol; 1989 Jun; 35(6):766-73. PubMed ID: 2543910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse regulation of calcium channels and beta-adrenergic receptors in virus-transformed human embryonal cells.
    Drímal J; Magna D; Knézl V; Tokárová J; Drímalová L
    Gen Physiol Biophys; 1991 Apr; 10(2):125-35. PubMed ID: 1713871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction.
    Sakurada S; Takuwa N; Sugimoto N; Wang Y; Seto M; Sasaki Y; Takuwa Y
    Circ Res; 2003 Sep; 93(6):548-56. PubMed ID: 12919947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.
    Flaim SF; Gleason MM; Hedberg A; Shank RP; McCullough JR; Gill A; Damiano BP; Brannan MD; Carson JR
    J Pharmacol Exp Ther; 1991 Jan; 256(1):279-88. PubMed ID: 1846419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of beta-adrenergic receptors and calcium channel agonist binding sites in cultured human embryonal smooth muscle cells.
    Drímal J
    Gen Physiol Biophys; 1989 Aug; 8(4):341-50. PubMed ID: 2475388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium and the endothelin-1 and alpha 1-adrenergic stimulated phosphatidylinositol cycle in cultured rat cardiomyocytes.
    van Heugten HA; de Jonge HW; Bezstarosti K; Lamers JM
    J Mol Cell Cardiol; 1994 Aug; 26(8):1081-93. PubMed ID: 7528283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
    Schoemaker H; Langer SZ
    J Pharmacol Exp Ther; 1989 Feb; 248(2):710-5. PubMed ID: 2537412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.